Skip to main content
. Author manuscript; available in PMC: 2020 Jul 17.
Published in final edited form as: Int J Obes (Lond). 2019 Jun 14;44(1):178–185. doi: 10.1038/s41366-019-0399-8

Fig. 1.

Fig. 1

T2 relaxation time and correlation analysis. Schematic representation of the regions of interest; 1, mediobasal hypothalamus (MBH); 2, amygdala; 3, putamen (a). T2 relaxation time in lean controls (CT), obese non-diabetic (ND) and patients with type 2 diabetes (T2D) obtained for MBH, amygdala and putamen (b). Correlations between T2 relaxation time in MBH and blood insulin (c) and HOMA-IR (d). HOMA-IR, homeostatic model assessment for insulin resistance. **P < 0.01